<DOC>
	<DOCNO>NCT01021267</DOCNO>
	<brief_summary>Assessment open trial standardize saw palmetto preparation positive influence sexual dysfunction patient BPH sexual dysfunction .</brief_summary>
	<brief_title>Clinical Study Assess Influence Saw Palmetto Preparation Patients With Benign Prostatic Hyperplasia ( BPH ) Sexual Dysfunctions</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Permixon</mesh_term>
	<criteria>Patients BPH sexual dysfunction ( erectile dysfunction decrease libido ) IPSS &gt; 4 BSFI , sexual drive question &lt; 5 Lack libido due psychic disease depressive mood Excessivly strong lack libido judgement investigator within last two month Patients severe vascular disorder ( microangiopathies ) Patients know neuropathy Severe diabetes mellitus Patients hypertension less two month stable antihypertensive medication Known bad compliance patient</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>sexual dysfunction</keyword>
	<keyword>benign prostatic hyperplasia</keyword>
	<keyword>saw palmetto</keyword>
</DOC>